Podcast Episodes

Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit

Episode 103

Stakeholders from across the healthcare industry — from manufacturers and consultants to outside counsel and government officials — recently convened in Chicago for the Medicaid Drug Rebate Program S…

Published on 10 hours ago

EU Data Act: Spotlight on Switching Requirements for Data Processing Services

Episode 102

In this episode of Connected With Latham, London partner Fiona Maclean, Paris partner Jean-Luc Juhan, and London counsel Alain Traill discuss significant new switching requirements due to take effect…

Published on 3 weeks ago

EU Data Act: Implications for Data Privacy and Cybersecurity

Episode 101

In this episode of Connected With Latham, London partner Gail Crawford and Frankfurt partner Tim Wybitul discuss the EU Data Act, and what this means for data privacy and cybersecurity practices.

T…

Published on 3 weeks, 1 day ago

The Leeds Reforms: Implications for UK Financial Services

Episode 100

In this episode of Connected with Latham, London partners Rob Moulton and Nicola Higgs discuss the UK government’s plans for the financial services sector, and key takeaways for financial services fi…

Published on 2 months, 2 weeks ago

Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference

Episode 99

Current developments, such as most favored nation (MFN) pricing, grabbed much of the spotlight when key industry stakeholders met in Philadelphia for the Pricing and Contracting USA Conference. In th…

Published on 3 months, 1 week ago

Drug Pricing: Takeaways from the MDMA Annual Meeting

Episode 98

Stakeholders from across the healthcare industry, including members of Congress, the US Food and Drug Administration, and the Center for Medicare and Medicaid Services, recently convened in Washingto…

Published on 3 months, 3 weeks ago

Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation

Episode 97

The “Lowering Drug Prices by Once Again Putting Americans First” Executive Order addresses various FDA matters, such as importation from Canada and accelerated approval of generics and biosimilars. I…

Published on 5 months ago

The Growth Rocketship: Shield AI’s Takeoff Shows What’s Possible in Defensetech

Episode 96

Founded in 2015, Shield AI uses technology and intelligence systems to protect service members and civilians. The venture-backed unicorn’s flagship autonomy software, Hivemind, powers aircraft, drone…

Published on 5 months ago

Drug Pricing: FDA in the Age of Executive Orders and DOGE

Episode 95

The initial months of the Trump administration have been marked by a flurry of executive orders and significant activity by the Department of Government Efficiency (DOGE). The US Food and Drug Admini…

Published on 6 months, 2 weeks ago

Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook

Episode 94

Stakeholders from across the healthcare and biopharmaceutical industry recently convened in San Francisco for the annual J.P. Morgan Healthcare Conference. In this episode of Connected With Latham, W…

Published on 7 months, 1 week ago